2024年
- December 16, 2024
- KYORIN and Bayer Enter into License Agreement for Novel Obstructive Sleep Apnea (OSA) Treatment
- December 6, 2024
- Notice of the relocation of the Nishinihon Distribution Center
- November 7, 2024
- Presentation document for Fiscal 2024 1st half (interim period) financial パチスロ 出 玉 制御
- November 7, 2024
- Consolidated Financial パチスロ 出 玉 制御 for the Six Months Ended September 30, 2024) [Japanese GAAP]
- November 7, 2024
- Consolidated Financial パチスロ 出 玉 制御 for Second Quarter (Interim Period) of FY2024 - Supplementary Information
- August 2, 2024
- Option Agreement for drug discovery of extracellular vesicles derived from airway epithelial cells
- July 31, 2024
- Summary of Consolidated Financial パチスロ 出 玉 制御(For the first quarter ended June 30, 2024) [Japanese GAAP]
- May 21, 2024
- Notice of Dividends of Retained Earnings
- May 10, 2024
- Summary of Consolidated Financial パチスロ 出 玉 制御(For fiscal year ended March 31, 2024) [Japanese GAAP]
- May 10, 2024
- Consolidated Financial パチスロ 出 玉 制御 for the Fiscal Year Ended March 31, 2024 (May 10 2024) - Supplementary Information
- April 15, 2024
- Starting Date of Operation at the New Head Office
- February 6, 2024
- Summary of Consolidated Financial パチスロ 出 玉 制御(For third quarter ended December 31, 2023) [Japanese GAAP]
- 1